Evidence map›Paper›PMID 40266128›Full record

ArticleVaccines2025

Pre-Existing Anti-Vector Immunity to Adenovirus-Inspired VLP Vaccines Shows an Adjuvant-Dependent Antagonism.

Salomé Gallet, Dalil Hannani, Sebastian Dergan-Dylon, Emilie Vassal-Stermann, Isabelle Bally, Christopher Chevillard, Daphna Fenel, Olivier Epaulard, Pascal Poignard, Pascal Fender

Abstract read
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Salomé GalletCNRS, CEA, IBS, Université Grenoble Alpes, F-38000 Grenoble, France.
Dalil HannaniUniversité Grenoble Alpes, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, TIMC, F-38400 Grenoble, France.ORCID 0000-0001-5097-1401
Sebastian Dergan-DylonCNRS, CEA, IBS, Université Grenoble Alpes, F-38000 Grenoble, France.
Emilie Vassal-StermannCNRS, CEA, IBS, Université Grenoble Alpes, F-38000 Grenoble, France.ORCID 0000-0002-8486-4935
Isabelle BallyCNRS, CEA, IBS, Université Grenoble Alpes, F-38000 Grenoble, France.ORCID 0000-0002-8315-6080
Christopher ChevillardCNRS, CEA, IBS, Université Grenoble Alpes, F-38000 Grenoble, France.ORCID 0000-0002-9370-6437
Daphna FenelCNRS, CEA, IBS, Université Grenoble Alpes, F-38000 Grenoble, France.
Olivier EpaulardClinical Infectious Disease Unit, Grenoble-Alpes University Hospital, F-38000 Grenoble, France.
Pascal PoignardCNRS, CEA, IBS, Université Grenoble Alpes, F-38000 Grenoble, France.
Pascal FenderCNRS, CEA, IBS, Université Grenoble Alpes, F-38000 Grenoble, France.ORCID 0000-0002-6698-3367

Funding

Région 'Auvergne Rhône-Alpes' Flash COVID 'CoV-Mime'
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adenovirusadjuvantpre-existing immunitySARS-CoV-2VLP

Identifiers

PMID40266128
PMCPMC11946745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.